{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:30:03Z","timestamp":1777635003710,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-025-05581-6","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:22:37Z","timestamp":1760012557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recrudescent severe malaria due to Plasmodium falciparum following treatment in a Taiwanese patient: a case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Yu-Chuan","family":"Tseng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Yu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Bor-Chian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Fen","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jen-Jen","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Cheng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao-Wang","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiung-Tzu","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"5581_CR1","volume-title":"Guidelines for malaria","author":"WHO","year":"2024","unstructured":"WHO. Guidelines for malaria. Geneva: World Health Organization; 2024."},{"key":"5581_CR2","volume-title":"Clinical guidance: Malaria diagnosis & treatment in the US","author":"US Centers for Disease Control and Prevention","year":"2024","unstructured":"US Centers for Disease Control and Prevention. Clinical guidance: Malaria diagnosis & treatment in the US. Atlanta: US Centers for Disease Control and Prevention; 2024."},{"key":"5581_CR3","volume-title":"Antimicrobial stewardship","author":"Sanford Guide","year":"2025","unstructured":"Sanford Guide. Antimicrobial stewardship. Sperryville: Antimicrobial Therapy Inc; 2025."},{"key":"5581_CR4","volume-title":"UK Malaria Expert Advisory Group interim guidance","author":"UK Health Security Agency","year":"2025","unstructured":"UK Health Security Agency. UK Malaria Expert Advisory Group interim guidance. London: UK Health Security Agency; 2025."},{"key":"5581_CR5","doi-asserted-by":"publisher","first-page":"7485","DOI":"10.1038\/s41467-024-51846-0","volume":"15","author":"J Tripathi","year":"2024","unstructured":"Tripathi J, Stoklasa M, Nayak S, En Low K, Qian Hui Lee E, Duong Tien QH, et al. The artemisinin-induced dormant stages of Plasmodium falciparum exhibit hallmarks of cellular quiescence\/senescence and drug resilience. Nat Commun. 2024;15:7485.","journal-title":"Nat Commun"},{"key":"5581_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.pt.2013.04.001","volume":"29","author":"S Krishna","year":"2013","unstructured":"Krishna S, Kremsner PG. Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy. Trends Parasitol. 2013;29:313\u20137.","journal-title":"Trends Parasitol"},{"key":"5581_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.62347\/RWLA6562","volume":"15","author":"M Ndiaye","year":"2024","unstructured":"Ndiaye M, Diouf M, Mhamadi M, Djigal A, Manga IA, Sene C, et al. P. falciparum genetic markers associated with drug resistance from patients with treatment failure in the Southern part of Senegal in 2017. Int J Mol Epidemiol Genet. 2024;15:22\u201330.","journal-title":"Int J Mol Epidemiol Genet"},{"key":"5581_CR8","volume-title":"Malaria","author":"Taiwan Centers for Disease Control","year":"2025","unstructured":"Taiwan Centers for Disease Control. Malaria. Taipei: Taiwan Centers for Disease Control; 2025."},{"key":"5581_CR9","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12936-022-04301-8","volume":"21","author":"NJ White","year":"2022","unstructured":"White NJ. Severe malaria. Malar J. 2022;21:284.","journal-title":"Malar J"},{"key":"5581_CR10","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1056\/NEJMra2405313","volume":"392","author":"JP Daily","year":"2025","unstructured":"Daily JP, Parikh S. Malaria. N Engl J Med. 2025;392:1320\u201333.","journal-title":"N Engl J Med"},{"key":"5581_CR11","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/S0140-6736(10)61924-1","volume":"376","author":"AM Dondorp","year":"2010","unstructured":"Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 2010;376:1647\u201357.","journal-title":"Lancet"},{"key":"5581_CR12","volume-title":"Statistical data on confirmed cases of legally designated infectious diseases imported from abroad","author":"Taiwan Centers for Disease Control","year":"2025","unstructured":"Taiwan Centers for Disease Control. Statistical data on confirmed cases of legally designated infectious diseases imported from abroad. Taipei: Taiwan Centers for Disease Control; 2025."},{"key":"5581_CR13","doi-asserted-by":"publisher","first-page":"707","DOI":"10.18203\/2349-3933.ijam20172132","volume":"4","author":"RK Yadav","year":"2017","unstructured":"Yadav RK, Kumar S. To study hematological profile in malaria patients. Int J Adv Med. 2017;4:707\u201312.","journal-title":"Int J Adv Med"},{"key":"5581_CR14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/s12879-021-06228-y","volume":"21","author":"AME Elkhalifa","year":"2021","unstructured":"Elkhalifa AME, Abdul-Ghani R, Tamomh AG, Eltaher NE, Ali NY, Ali MM, et al. Hematological indices and abnormalities among patients with uncomplicated falciparum malaria in Kosti city of the White Nile state, Sudan: a comparative study. BMC Infect Dis. 2021;21:507.","journal-title":"BMC Infect Dis"},{"key":"5581_CR15","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S0035-9203(02)90100-8","volume":"96","author":"AM Dondorp","year":"2002","unstructured":"Dondorp AM, Nyanoti M, Kager PA, Mithwani S, Vreeken J, Marsh K. The role of reduced red cell deformability in the pathogenesis of severe falciparum malaria and its restoration by blood transfusion. Trans R Soc Trop Med Hyg. 2002;96:282\u20136.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5581_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.molbiopara.2014.07.006","volume":"195","author":"JD Smith","year":"2014","unstructured":"Smith JD. The role of PfEMP1 adhesion domain classification in Plasmodium falciparum pathogenesis research. Mol Biochem Parasitol. 2014;195:82\u20137.","journal-title":"Mol Biochem Parasitol"},{"key":"5581_CR17","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1002\/eji.201747032","volume":"47","author":"JA Chan","year":"2017","unstructured":"Chan JA, Stanisic DI, Duffy MF, Robinson LJ, Lin E, Kazura JW, et al. Patterns of protective associations differ for antibodies to P. falciparum-infected erythrocytes and merozoites in immunity against malaria in children. Eur J Immunol. 2017;47:2124\u201336.","journal-title":"Eur J Immunol"},{"key":"5581_CR18","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1002\/pmic.201400508","volume":"15","author":"E Lasonder","year":"2015","unstructured":"Lasonder E, Green JL, Grainger M, Langsley G, Holder AA. Extensive differential protein phosphorylation as intraerythrocytic Plasmodium falciparum schizonts develop into extracellular invasive merozoites. Proteomics. 2015;15:2716\u201329.","journal-title":"Proteomics"},{"key":"5581_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12936-018-2174-z","volume":"17","author":"J Lin","year":"2018","unstructured":"Lin J, Huang X, Qin G, Zhang S, Sun W, Wang Y, et al. Manual exchange transfusion for severe imported falciparum malaria: a retrospective study. Malar J. 2018;17:32.","journal-title":"Malar J"},{"key":"5581_CR20","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jmii.2019.07.006","volume":"53","author":"MT Zaw","year":"2020","unstructured":"Zaw MT, Lin Z, Emran NA. Importance of kelch 13 C580Y mutation in the studies of artemisinin resistance in Plasmodium falciparum in Greater Mekong Subregion. J Microbiol Immunol Infect. 2020;53:676\u201381.","journal-title":"J Microbiol Immunol Infect"},{"key":"5581_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/cid\/ciw710","volume":"64","author":"K Sonden","year":"2017","unstructured":"Sonden K, Wyss K, Jovel I, Vieira da Silva A, Pohanka A, Asghar M, et al. High Rate of treatment failures in nonimmune travelers treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Sweden: retrospective comparative analysis of effectiveness and case series. Clin Infect Dis. 2017;64:199\u2013206.","journal-title":"Clin Infect Dis"},{"key":"5581_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijpddr.2021.06.001","volume":"16","author":"L Ndwiga","year":"2021","unstructured":"Ndwiga L, Kimenyi KM, Wamae K, Osoti V, Akinyi M, Omedo I, et al. A review of the frequencies of Plasmodium falciparum kelch 13 artemisinin resistance mutations in Africa. Int J Parasitol Drugs Drug Resist. 2021;16:155\u201361.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5581_CR23","doi-asserted-by":"publisher","first-page":"e66277","DOI":"10.7554\/eLife.66277","volume":"10","author":"BH Stokes","year":"2021","unstructured":"Stokes BH, Dhingra SK, Rubiano K, Mok S, Straimer J, Gnadig NF, et al. Plasmodium falciparum k13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness. Elife. 2021;10:e66277.","journal-title":"Elife"},{"key":"5581_CR24","doi-asserted-by":"publisher","first-page":"e0305064","DOI":"10.1371\/journal.pone.0305064","volume":"19","author":"MK Angwe","year":"2024","unstructured":"Angwe MK, Mwebaza N, Nsobya SL, Vudriko P, Dralabu S, Omali D, et al. Day 3 parasitemia and Plasmodium falciparum kelch 13 mutations among uncomplicated malaria patients treated with artemether-lumefantrine in Adjumani district, Uganda. PLoS ONE. 2024;19:e0305064.","journal-title":"PLoS ONE"},{"key":"5581_CR25","doi-asserted-by":"publisher","first-page":"107707","DOI":"10.1016\/j.intimp.2021.107707","volume":"97","author":"S Shokouhi","year":"2021","unstructured":"Shokouhi S, Barati S, Kazeminia N, Jamali F, Roshan B, Sahraei Z. Evaluating the elimination status of medications used for COVID-19 during hemoperfusion and therapeutic plasma exchange: a review. Int Immunopharmacol. 2021;97:107707.","journal-title":"Int Immunopharmacol"},{"key":"5581_CR26","doi-asserted-by":"publisher","first-page":"5484","DOI":"10.1128\/AAC.00044-12","volume":"56","author":"D Saunders","year":"2012","unstructured":"Saunders D, Khemawoot P, Vanachayangkul P, Siripokasupkul R, Bethell D, Tyner S, et al. Pharmacokinetics and pharmacodynamics of oral artesunate monotherapy in patients with uncomplicated Plasmodium falciparum malaria in western Cambodia. Antimicrob Agents Chemother. 2012;56:5484\u201393.","journal-title":"Antimicrob Agents Chemother"},{"key":"5581_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12028-020-00989-1","volume":"34","author":"SH Mahmoud","year":"2021","unstructured":"Mahmoud SH, Buhler J, Chu E, Chen SA, Human T. Drug dosing in patients undergoing therapeutic plasma exchange. Neurocrit Care. 2021;34:301\u201311.","journal-title":"Neurocrit Care"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05581-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05581-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05581-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:22:38Z","timestamp":1760012558000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05581-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5581"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05581-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7000518\/v1","asserted-by":"object"}]},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"29 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The need for ethical approval was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Before preparing the case report, the patient provided written informed consent to write the case and be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"325"}}